The Evolving Landscape of Female-Specific Cardiovascular Care
Join NJ-ACC on February 12th to hear our distinguished faculty of national experts discuss the latest 2026 guidelines, biological risk factors, and the complexities of menopausal transition beginning at 7:00 p.m.
Click Here to Register.
Lecture 1 | Biological Blueprints: Sex-Specific Risk Factors
Speaker: Rekha Mankad, MD, FACC (15 mins)
- Identify unique sex-specific risk enhancers: preeclampsia, gestational diabetes, premature menopause, and PCOS.
- Differentiate the disproportionately higher relative risk of traditional factors (smoking, DM, HTN) in women.
- Explain the influence of Sex as a Biological Variable (SABV) on vascular aging from menarche through menopause.
Lecture 2 | 2026 CV Prevention Update: Translating Guidelines
Speaker: Gina Lundberg, MD, FACC (15 mins)
- Implement updated 2026 risk-stratification algorithms for primary prevention.
- Apply tailored lipid-lowering and hypertension thresholds for women at various life stages.
- Develop strategies to improve GDMT adherence, addressing microvascular disease and statin-associated symptoms.
Lecture 3 | Navigating Menopause and Cardiovascular Risk
Speaker: Martha Gulati, MD, MS, FACC (15 mins)
- Assess CV risk prior to Menopausal Hormone Therapy (MHT) using traditional calculators and imaging/biomarkers.
- Differentiate contraindications to systemic hormone therapy in high-risk CVD patients.
- Develop shared decision-making strategies and non-hormonal alternatives for symptomatic women.
Expert Panel & Clinical Roundtable (15 mins)
Moderator: Sheila Sahni, MD (Chair, NJ-ACC Women in Cardiology)
Join our panelists and speakers for an interactive discussion on translating these lectures into daily clinical practice: Renee Bullock-Palmer, MD; Amy Ahnert, MD; Aviva Cohn, MD
*This program is pending accreditation approval for 1.5 hours of ACCME, ANCC, and AAPA credit.
